Investing.com - Thermo Fisher Scientific reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Thermo Fisher Scientific announced earnings per share of $3.55 on revenue of $6.83B. Analysts polled by Investing.com anticipated EPS of $3.54 on revenue of $6.78B. That with comparison to EPS of $3.25 on revenue of $6.51B in the same period a year before. Thermo Fisher Scientific had reported EPS of $2.94 on revenue of $6.27B in the previous quarter. Analysts are expecting EPS of $3.06 and revenue of $6.42B in the upcoming quarter.
Thermo Fisher Scientific shares are up 2.78% from the beginning of the year and are trading at $333.89 , still down 2.45% from its 52 week high of $342.26 set on January 22. They are outperforming the S&P 500 which is up 0.87% year to date.
Thermo Fisher Scientific follows other major Healthcare sector earnings this month
Thermo Fisher Scientific's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Novartis ADR had beat expectations on Wednesday with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar